News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
392,399 Results
Type
Article (11731)
Company Profile (66)
Press Release (380600)
Multimedia
Podcasts (8)
Webinars (3)
Section
Business (123890)
Career Advice (403)
Deals (21550)
Drug Delivery (39)
Drug Development (43522)
Employer Resources (36)
FDA (8653)
Job Trends (10529)
News (198887)
Policy (17093)
Tag
Academia (1683)
Accelerated approval (6)
Adcomms (6)
Allergies (84)
Alliances (21353)
ALS (81)
Alzheimer's disease (870)
Antibody-drug conjugate (ADC) (108)
Approvals (8805)
Artificial intelligence (194)
Autoimmune disease (18)
Automation (14)
Bankruptcy (147)
Best Places to Work (9398)
BIOSECURE Act (10)
Biosimilars (60)
Biotechnology (44)
Bladder cancer (76)
Brain cancer (22)
Breast cancer (296)
Cancer (2261)
Cardiovascular disease (182)
Career advice (334)
Career pathing (8)
CAR-T (136)
CDC (5)
Cell therapy (353)
Cervical cancer (22)
Clinical research (37877)
Collaboration (677)
Compensation (405)
Complete response letters (22)
COVID-19 (1235)
CRISPR (46)
C-suite (274)
Cystic fibrosis (76)
Data (2784)
Depression (45)
Diabetes (226)
Diagnostics (4429)
Digital health (13)
Diversity (3)
Diversity, equity & inclusion (11)
Drug discovery (80)
Drug pricing (42)
Drug shortages (8)
Duchenne muscular dystrophy (96)
Earnings (72449)
Editorial (17)
Employer branding (6)
Employer resources (33)
Events (77163)
Executive appointments (548)
FDA (10266)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (636)
Gene editing (103)
Generative AI (10)
Gene therapy (247)
GLP-1 (385)
Government (2554)
Grass and pollen (4)
Guidances (325)
Healthcare (15109)
HIV (28)
Huntington's disease (17)
IgA nephropathy (34)
Immunology and inflammation (94)
Immuno-oncology (8)
Indications (36)
Infectious disease (1334)
Inflammatory bowel disease (120)
Inflation Reduction Act (5)
Influenza (53)
Intellectual property (88)
Interviews (62)
IPO (12658)
IRA (8)
Job creations (1418)
Job search strategy (295)
Kidney cancer (8)
Labor market (31)
Layoffs (235)
Leadership (3)
Legal (3534)
Liver cancer (44)
Longevity (6)
Lung cancer (347)
Lymphoma (188)
Machine learning (9)
Management (11)
Manufacturing (269)
MASH (69)
Medical device (9746)
Medtech (9757)
Mergers & acquisitions (9529)
Metabolic disorders (499)
Multiple sclerosis (74)
NASH (5)
Neurodegenerative disease (87)
Neuropsychiatric disorders (16)
Neuroscience (1413)
NextGen: Class of 2025 (5232)
Non-profit (4225)
Now hiring (18)
Obesity (209)
Opinion (72)
Ovarian cancer (86)
Pain (92)
Pancreatic cancer (95)
Parkinson's disease (144)
Partnered (9)
Patents (181)
Patient recruitment (158)
Peanut (40)
People (27594)
Pharmaceutical (13)
Pharmacy benefit managers (7)
Phase I (11231)
Phase II (16644)
Phase III (13492)
Pipeline (1943)
Policy (54)
Postmarket research (1182)
Preclinical (3895)
Press Release (61)
Prostate cancer (102)
Psychedelics (11)
Radiopharmaceuticals (152)
Rare diseases (322)
Real estate (2764)
Recruiting (15)
Regulatory (12836)
Reports (20)
Research institute (1495)
Resumes & cover letters (72)
Rett syndrome (10)
RNA editing (4)
RSV (21)
Schizophrenia (77)
Series A (105)
Series B (82)
Service/supplier (5)
Sickle cell disease (45)
Special edition (10)
Spinal muscular atrophy (90)
Sponsored (15)
Startups (1330)
State (1)
Stomach cancer (3)
Supply chain (37)
Tariffs (22)
The Weekly (8)
Vaccines (350)
Venture capital (18)
Weight loss (101)
Women's health (24)
Worklife (3)
Date
Today (66)
Last 7 days (243)
Last 30 days (1261)
Last 365 days (22377)
2025 (16308)
2024 (22582)
2023 (26924)
2022 (30893)
2021 (34999)
2020 (37341)
2019 (37139)
2018 (27039)
2017 (19874)
2016 (19677)
2015 (23177)
2014 (12764)
2013 (9617)
2012 (10164)
2011 (10407)
2010 (9421)
Location
Africa (285)
Alabama (50)
Alaska (2)
Arizona (145)
Arkansas (7)
Asia (24020)
Australia (3141)
California (6009)
Canada (1589)
China (666)
Colorado (254)
Connecticut (237)
Delaware (182)
Europe (46465)
Florida (906)
Georgia (216)
Idaho (38)
Illinois (477)
India (30)
Indiana (343)
Iowa (12)
Japan (185)
Kansas (70)
Kentucky (26)
Louisiana (14)
Maine (59)
Maryland (901)
Massachusetts (4457)
Michigan (172)
Minnesota (371)
Mississippi (3)
Missouri (78)
Montana (25)
Nebraska (15)
Nevada (67)
New Hampshire (59)
New Jersey (1816)
New Mexico (18)
New York (1724)
North Carolina (884)
North Dakota (4)
Northern California (2832)
Ohio (196)
Oklahoma (11)
Oregon (20)
Pennsylvania (1312)
Puerto Rico (6)
Rhode Island (28)
South America (526)
South Carolina (30)
South Dakota (1)
Southern California (2310)
Tennessee (91)
Texas (916)
United States (22494)
Utah (199)
Virginia (159)
Washington D.C. (47)
Washington State (490)
West Virginia (1)
Wisconsin (41)
392,399 Results for "30".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Interim results for the six months ended June 30, 2025
September 15, 2025
·
33 min read
Layoffs
AC Immune Downsizes by 30%, Narrows Pipeline Focus
The reprioritization effort will help AC Immune extend its cash runway through the third quarter of 2027.
September 4, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Update on Information Relating to the General Meeting of September 30, 2025
September 12, 2025
·
4 min read
Press Releases
OmniAb Announces $30 Million Private Placement
August 25, 2025
·
4 min read
Press Releases
Ocular Therapeutix™ to Host Investor Day on September 30, 2025
September 8, 2025
·
8 min read
Job Trends
$30M in Tax Incentives Fuel Job Growth: 1,500+ New Roles Coming to Massachusetts
Nearly $30 million in tax incentive awards are expected to add 1,519 new life sciences jobs in Massachusetts, with about 52% of the positions spread over Boston and Cambridge. Vertex, which received the largest award, will create hundreds of roles in Boston.
June 17, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025
August 18, 2025
·
5 min read
Press Releases
Artelo Biosciences Announces Closing of $3.0 Million Public Offering
September 8, 2025
·
4 min read
Press Releases
Artelo Biosciences Announces Pricing of $3.0 Million Public Offering
September 5, 2025
·
4 min read
Press Releases
Scancell reports Business Update and Financial Results for the Year Ended 30 April 2025
September 11, 2025
·
43 min read
1 of 39,240
Next
